|
2026
|
P/S
|
Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergi... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hemat... |
|
|
P/S
|
Promoting public awareness of osteoporosis, management of osteoporosis and fracture risk reductio... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of
cancer, oncology, tumors, solid and hema... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes,
endocrine diseases and disorders, met... |
|
|
P/S
|
Providing online non-downloadable informational content in the field of musculoskeletal health an... |
|
|
P/S
|
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoim... |
|
|
P/S
|
Pharmaceutical preparations for treating alopecia,
Alzheimer's disease, atopic dermatitis, autoi... |
|
|
P/S
|
Pharmaceutical preparations for treating alopecia,
alzheimer's disease, atopic dermatitis, autoi... |
|
|
P/S
|
Retail pharmacy services, namely, retail services for pharmaceuticals, pharmaceutical preparation... |
|
|
P/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
|
Invention
|
Combination of lilrb1/2 pathway inhibitors and pd-1 pathway inhibitors.
This invention relates t... |
|
|
P/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
P/S
|
pharmaceutical preparations;pharmaceutical preparations for the treatment of cancer;pharmaceutica... |
|
|
P/S
|
educational services, namely development and dissemination of educational materials in the field ... |
|
|
Invention
|
Formulations of apremilast.
Provided herein are oral dosage forms comprising a) a core tablet co... |
|
|
Invention
|
The use of low molecular weight polyvinylpyrrolidone (pvp) to reduce viscosity of high concentrat... |
|
|
Invention
|
Systems and methods for automated in-line plunger depth measurement.
A system, comprising: one o... |
|
|
Invention
|
Data-driven predictive modeling for cell line selection in biopharmaceutical production.
A metho... |
|
|
Invention
|
Combination therapy including a kras g12c inhibitor and one or more additional pharmaceutically a... |
|
|
P/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
Invention
|
Hybrid predictive modeling for control of cell culture.
A method of controlling a cell culture p... |
|
|
Invention
|
Compounds as modulators of igf-1r and uses thereof. Disclosed herein are compounds useful for the... |
|
|
Invention
|
Automated gradient patch cell plating. The present disclosure relates to an automated method for ... |
|
|
Invention
|
Heterocyclic inhibitors of igf-1r and uses thereof.
Disclosed herein are compounds useful for th... |
|
|
Invention
|
Heterocyclic inhibitors of igf-1r and uses thereof. Disclosed herein are compounds useful for the... |
|
|
Invention
|
Optic labels for drug storage containers. Devices for storing a drug, placebo, and/or other subst... |
|
|
Invention
|
Systems and methods for inspecting products on a production line. Systems for inspecting one or m... |
|
2025
|
Invention
|
Convergent peptide synthesis methods.
Convergent pathways for the preparation of a peptide by so... |
|
|
Invention
|
Convergent peptide synthesis methods. Convergent pathways for the preparation of a peptide by sol... |
|
|
Invention
|
T cell engager masking molecules with reduced isomerization tendencies. The present invention rel... |
|
|
Invention
|
Methods of diethylenetriaminepentaacetic acid (dtpa) quantification. Provided herein are methods ... |
|
|
Invention
|
Drug delivery devices and flange extension members. Drug delivery devices and flange extension me... |
|
|
Invention
|
Polycyclic compounds as modulators of stat6 and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Compounds as modulators of stat6 and uses thereof.
Disclosed herein are compounds useful for the... |
|
|
Invention
|
Therapeutic compositions, combinations, and methods of use. This disclosure relates to methods of... |
|
|
Invention
|
Processes for preparing a mdm2 inhibitor.
The present invention provides commercial processes fo... |
|
|
Invention
|
Load vessel draining system and method. A load vessel draining system for use with a drug purific... |
|
|
Invention
|
Biological detection systems and methods for setting medically suitable target ranges of attribut... |
|
|
Invention
|
Next-generation sequencing platform for sequence variant analysis of manufacturing cell lines. Me... |
|
|
Invention
|
Bispecific lymphotoxin b receptor binding proteins. The present disclosure is directed to bispeci... |
|
|
Invention
|
Harmaceutica formulations comprising a monoclonal antibody.
The present invention relates to met... |
|
|
Invention
|
Chimeric receptors to steap1 and methods of use thereof.
Antigen binding molecules, chimeric rec... |
|
|
Invention
|
Sotorasib dosing regimen.
The present disclosure provides method of administering sotorasib to a... |
|
|
Invention
|
Methods for increasing mannose content of recombinant proteins.
The present invention relates to... |
|
|
Invention
|
Solid state forms.
The present disclosure provides crystalline and amorphous forms of 6-fluoro-7... |
|
|
Invention
|
Solid forms of macrocyclic compounds and uses thereof.
The disclosure provides solid forms of Co... |
|
|
Invention
|
5-membered core compounds as modulators of werner syndrome recq dna helicase and uses thereof.
D... |
|
2024
|
Invention
|
Automated visual inspection of prefilled syringes.
A system for measuring an air gap in a syring... |
|
|
Invention
|
System and method for analyzing antibody co-formulations.
The disclosure provides systems and me... |
|
|
Invention
|
Cell culture methods.
The disclosure provides non-steady state continuous perfusion cell culture... |
|
2023
|
Invention
|
Rnai constructs for inhibiting ttr expression and methods of use thereof.
The disclosure relates... |
|
|
Invention
|
Methods for treating dll3-expressing cancer.
The disclosure provides methods for treating small ... |
|
|
Invention
|
Solid forms of naphthyridine compounds.
Disclosed herein are various solid forms of Compound A, ... |
|
|
Invention
|
Selection of patients for the treatment of fads1-mediated diseases or disorders using fads-1 inhi... |
|
|
Invention
|
Macrocyclic compounds and methods of use.
The present disclosure provides compounds useful for t... |
|
|
Invention
|
Methods for treating obesity.
The present invention relates to methods of treating obesity or ty... |
|
|
Invention
|
Systems and methods for performing line clearance and monitoring.
Systems and methods of perform... |
|
|
Invention
|
Methods of antibody characterization.
The present disclosure relates to methods of characterizin... |
|
|
Invention
|
Compositions of anti-interleukin 12/interleukin 23 antibody.
Pharmaceutical compositions compris... |
|
|
Invention
|
Anti-tslp antibody compositions and uses thereof.
The present application relates, in general, t... |
|
|
Invention
|
Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof.
The present disc... |
|
2022
|
Invention
|
Protection of therapeutic proteins.
The disclosure relates to methods of improving sialic acid c... |
|
|
Invention
|
Deep learning-based prediction using spectroscopy.
A method for monitoring and/or controlling a ... |
|
2020
|
Invention
|
Systems and methods for preparing a sample and performing a real-time assay of the sample. System... |
